Quantitative real-time polymerase chain reaction and western blotting demonstrated that D-2-HG dehydrogenase (D2HGDH) mRNAs and protein expression were decreased in patients with BA (Fig. 2B, C). The gene discussed is D2HGDH; the disease is breast angiosarcoma.